The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Consumer Alert: Slimming Beauty Bitter Orange Slimming Capsules

    So good they had to name it “slimming” twice.

    Unfortunately, Slimming Beauty contains the active pharmaceutical ingredient sibutramine (Meridia), a stimulant. And the marketer, Beautiful Health Inc., formerly LL Health and Beauty, failed to list it among the ingredients on the label.

    Slimming Beauty could harm users, especially those with cardiovascular conditions, because it can lead to elevated blood pressure, stroke, and heart attack.

    Consumers who are otherwise healthy and who take the amount of sibutramine found in Slimming Beauty capsules can experience anxiety, nausea, heart palpitations, a racing heart, insomnia, and elevated blood pressure. Sibutramine also may interact with other medications and can cause serious side effects; 781 drugs are known to interact with silbutramine.

    The bottom line?

    As with other misbranded and misleading drugs, consumers should discontinue Slimming Beauty immediately.

    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of this product to the FDA’s MedWatch Safety Information and Adverse Event Reporting.

    Even as a prescription drug, sibutramine isn’t safe. Abbott Laboratories announced today that it will withdraw Meridia, which contains sibutramine, from the market because of concerns that it increases the risk of heart attacks and strokes.

    Abbott will pull the drug from the Canadian and the Australian markets as well. It was removed from European markets in January 2010.

    10/8/10 16:45 JR

    Leave a Comment

    You must be logged in to post a comment.